Crystal Arthropathies — Written Clinical Reasoning · Phys Written Answers

Prompt

DCE-style written reasoning for Crystal Arthropathies.

SAQ 1 — Integrated plan (12 marks)

Prompt: Provide a prioritised problem list and management sequence for this presentation. [1] [2]

Model Answer

1. Frame and red flags (3 marks) [1]

State the working diagnosis/syndrome, acuity, and what would force emergency treatment now. [1] [2]

2. Discriminating assessment (3 marks) [2]

List the key history, examination and investigations that separate dangerous differentials from benign mimics. [1] [2]

3. Treatment sequence (4 marks) [1] [3]

Immediate stabilisation, disease-specific therapy, monitoring, and complications prevention. [1] [2] [3]

4. Follow-up and communication (2 marks) [2]

Disposition, safety-net advice, and who owns follow-up. [1] [2]

SAQ 2 — Exam trap defence (8 marks)

Prompt: Name two high-yield traps in Crystal Arthropathies and how you avoid them. [1] [2]

Model Answer

Trap one: delayed escalation of a high-risk feature — avoid by explicit red-flag checklist. [1]

Trap two: therapy mismatched to mechanism — avoid by confirming the discriminating test before escalating treatment. [2] [3]

References

[1]Liu Q, Li X, Lin Y, Tang X, et al. Multidimensional therapeutic advantages of Smilax glabra (Tufuling)-containing formulae in gout: an integrated Systematic Review and network pharmacology-based prediction Front Endocrinol (Lausanne), 2026.PMID 42460320
[2]Atzeni F, Bartoloni E, Antonini C, Castellucci A, et al. Colchicine in crystal synovitis and beyond Clin Exp Rheumatol, 2026.PMID 42454465
[3]Gao L, Ye G, Liu C, Gao Y, et al. Prevalence and risk factors of hyperuricemia and gout in patients with type 2 diabetes mellitus: a systematic review and meta-analysis Front Endocrinol (Lausanne), 2026.PMID 42422434
[4]Shao Z, Zhang Y, Cheng B, Zhang F, et al. Accuracy and readability of LLM-generated responses for gout management: a benchmark study based on ACR guidelines Clin Rheumatol, 2026.PMID 41941089
[5]Meral HB, Kolak E Evaluation of ChatGPT-4o and Gemini for gout management: a comparative analysis based on EULAR guidelines Sci Rep, 2026.PMID 41495169
[6]Xi Y, Yao T, Zhang C, Zhuang T Effectiveness of safety care and clinical nursing pathway in patients undergoing cardiovascular intervention: a randomized controlled trial Perioper Med (Lond), 2026.PMID 42469924
[7]Marks FJ, Walters SJ, Sutton L, Jacques RM What statistical methods are more appropriate for predicting recruitment at the design stage of a randomised controlled trial? Trials, 2026.PMID 42469922
[8]Hajiaqaei M, Mohammadi A Transcranial random noise stimulation (tRNS) over the left dorsolateral prefrontal cortex ameliorates emotion dysregulation and executive function: a single-blind, randomized, sham-controlled clinical trial BMC Psychol, 2026.PMID 42469906

SAQ 1 — Integrated plan (12 marks)

Prompt: Provide a prioritised problem list and management sequence for this presentation. [1] [2]

Model Answer

1. Frame and red flags (3 marks) [1]

State the working diagnosis/syndrome, acuity, and what would force emergency treatment now. [1] [2]

2. Discriminating assessment (3 marks) [2]

List the key history, examination and investigations that separate dangerous differentials from benign mimics. [1] [2]

3. Treatment sequence (4 marks) [1] [3]

Immediate stabilisation, disease-specific therapy, monitoring, and complications prevention. [1] [2] [3]

4. Follow-up and communication (2 marks) [2]

Disposition, safety-net advice, and who owns follow-up. [1] [2]

SAQ 2 — Exam trap defence (8 marks)

Prompt: Name two high-yield traps in Crystal Arthropathies and how you avoid them. [1] [2]

Model Answer

Trap one: delayed escalation of a high-risk feature — avoid by explicit red-flag checklist. [1]

Trap two: therapy mismatched to mechanism — avoid by confirming the discriminating test before escalating treatment. [2] [3]

References

[1]Liu Q, Li X, Lin Y, Tang X, et al. Multidimensional therapeutic advantages of Smilax glabra (Tufuling)-containing formulae in gout: an integrated Systematic Review and network pharmacology-based prediction Front Endocrinol (Lausanne), 2026.PMID 42460320
[2]Atzeni F, Bartoloni E, Antonini C, Castellucci A, et al. Colchicine in crystal synovitis and beyond Clin Exp Rheumatol, 2026.PMID 42454465
[3]Gao L, Ye G, Liu C, Gao Y, et al. Prevalence and risk factors of hyperuricemia and gout in patients with type 2 diabetes mellitus: a systematic review and meta-analysis Front Endocrinol (Lausanne), 2026.PMID 42422434
[4]Shao Z, Zhang Y, Cheng B, Zhang F, et al. Accuracy and readability of LLM-generated responses for gout management: a benchmark study based on ACR guidelines Clin Rheumatol, 2026.PMID 41941089
[5]Meral HB, Kolak E Evaluation of ChatGPT-4o and Gemini for gout management: a comparative analysis based on EULAR guidelines Sci Rep, 2026.PMID 41495169
[6]Xi Y, Yao T, Zhang C, Zhuang T Effectiveness of safety care and clinical nursing pathway in patients undergoing cardiovascular intervention: a randomized controlled trial Perioper Med (Lond), 2026.PMID 42469924
[7]Marks FJ, Walters SJ, Sutton L, Jacques RM What statistical methods are more appropriate for predicting recruitment at the design stage of a randomised controlled trial? Trials, 2026.PMID 42469922
[8]Hajiaqaei M, Mohammadi A Transcranial random noise stimulation (tRNS) over the left dorsolateral prefrontal cortex ameliorates emotion dysregulation and executive function: a single-blind, randomized, sham-controlled clinical trial BMC Psychol, 2026.PMID 42469906